Global Next-Generation Immunology Drugs Market Growth (Status and Outlook) 2026-2032
The global Next-Generation Immunology Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Next-Generation Immunology Drugs Industry Forecast” looks at past sales and reviews total world Next-Generation Immunology Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Next-Generation Immunology Drugs sales for 2026 through 2032. With Next-Generation Immunology Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next-Generation Immunology Drugs industry.
This Insight Report provides a comprehensive analysis of the global Next-Generation Immunology Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Next-Generation Immunology Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Next-Generation Immunology Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next-Generation Immunology Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next-Generation Immunology Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Next-Generation Immunology Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Next-Generation Immunology Drugs Industry Forecast” looks at past sales and reviews total world Next-Generation Immunology Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Next-Generation Immunology Drugs sales for 2026 through 2032. With Next-Generation Immunology Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next-Generation Immunology Drugs industry.
This Insight Report provides a comprehensive analysis of the global Next-Generation Immunology Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Next-Generation Immunology Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Next-Generation Immunology Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next-Generation Immunology Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next-Generation Immunology Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Next-Generation Immunology Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Cell Therapy
- Small Molecule Drug
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer Inc
- Abbvie Inc.
- Johnson and Johnson
- F. Hoffmann-La Roche Ltd.
- Amgen Inc.
- Novartis AG
- Astellas Pharma Inc.
- Bristol-Myers Squibb Company
- Merck & Co., Inc.
- Eli Lilly and Company
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Next-Generation Immunology Drugs Market Size (2021-2032)
2.1.2 Next-Generation Immunology Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Next-Generation Immunology Drugs by Country/Region (2021, 2025 & 2032)
2.2 Next-Generation Immunology Drugs Segment by Type
2.2.1 Cell Therapy
2.2.2 Small Molecule Drug
2.2.3 Others
2.2.4 Next-Generation Immunology Drugs Market Size by Type
2.2.4.1 Next-Generation Immunology Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Next-Generation Immunology Drugs Market Size Market Share by Type (2021-2026)
2.3 Next-Generation Immunology Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Next-Generation Immunology Drugs Market Size by Application
2.3.4.1 Next-Generation Immunology Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Next-Generation Immunology Drugs Market Size Market Share by Application (2021-2026)
3 NEXT-GENERATION IMMUNOLOGY DRUGS MARKET SIZE BY PLAYER
3.1 Next-Generation Immunology Drugs Market Size Market Share by Player
3.1.1 Global Next-Generation Immunology Drugs Revenue by Player (2021-2026)
3.1.2 Global Next-Generation Immunology Drugs Revenue Market Share by Player (2021-2026)
3.2 Global Next-Generation Immunology Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEXT-GENERATION IMMUNOLOGY DRUGS BY REGION
4.1 Next-Generation Immunology Drugs Market Size by Region (2021-2026)
4.2 Global Next-Generation Immunology Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Next-Generation Immunology Drugs Market Size Growth (2021-2026)
4.4 APAC Next-Generation Immunology Drugs Market Size Growth (2021-2026)
4.5 Europe Next-Generation Immunology Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa Next-Generation Immunology Drugs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Next-Generation Immunology Drugs Market Size by Country (2021-2026)
5.2 Americas Next-Generation Immunology Drugs Market Size by Type (2021-2026)
5.3 Americas Next-Generation Immunology Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Next-Generation Immunology Drugs Market Size by Region (2021-2026)
6.2 APAC Next-Generation Immunology Drugs Market Size by Type (2021-2026)
6.3 APAC Next-Generation Immunology Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Next-Generation Immunology Drugs Market Size by Country (2021-2026)
7.2 Europe Next-Generation Immunology Drugs Market Size by Type (2021-2026)
7.3 Europe Next-Generation Immunology Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Next-Generation Immunology Drugs by Region (2021-2026)
8.2 Middle East & Africa Next-Generation Immunology Drugs Market Size by Type (2021-2026)
8.3 Middle East & Africa Next-Generation Immunology Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEXT-GENERATION IMMUNOLOGY DRUGS MARKET FORECAST
10.1 Global Next-Generation Immunology Drugs Forecast by Region (2027-2032)
10.1.1 Global Next-Generation Immunology Drugs Forecast by Region (2027-2032)
10.1.2 Americas Next-Generation Immunology Drugs Forecast
10.1.3 APAC Next-Generation Immunology Drugs Forecast
10.1.4 Europe Next-Generation Immunology Drugs Forecast
10.1.5 Middle East & Africa Next-Generation Immunology Drugs Forecast
10.2 Americas Next-Generation Immunology Drugs Forecast by Country (2027-2032)
10.2.1 United States Market Next-Generation Immunology Drugs Forecast
10.2.2 Canada Market Next-Generation Immunology Drugs Forecast
10.2.3 Mexico Market Next-Generation Immunology Drugs Forecast
10.2.4 Brazil Market Next-Generation Immunology Drugs Forecast
10.3 APAC Next-Generation Immunology Drugs Forecast by Region (2027-2032)
10.3.1 China Next-Generation Immunology Drugs Market Forecast
10.3.2 Japan Market Next-Generation Immunology Drugs Forecast
10.3.3 Korea Market Next-Generation Immunology Drugs Forecast
10.3.4 Southeast Asia Market Next-Generation Immunology Drugs Forecast
10.3.5 India Market Next-Generation Immunology Drugs Forecast
10.3.6 Australia Market Next-Generation Immunology Drugs Forecast
10.4 Europe Next-Generation Immunology Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market Next-Generation Immunology Drugs Forecast
10.4.2 France Market Next-Generation Immunology Drugs Forecast
10.4.3 UK Market Next-Generation Immunology Drugs Forecast
10.4.4 Italy Market Next-Generation Immunology Drugs Forecast
10.4.5 Russia Market Next-Generation Immunology Drugs Forecast
10.5 Middle East & Africa Next-Generation Immunology Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market Next-Generation Immunology Drugs Forecast
10.5.2 South Africa Market Next-Generation Immunology Drugs Forecast
10.5.3 Israel Market Next-Generation Immunology Drugs Forecast
10.5.4 Turkey Market Next-Generation Immunology Drugs Forecast
10.6 Global Next-Generation Immunology Drugs Forecast by Type (2027-2032)
10.7 Global Next-Generation Immunology Drugs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Next-Generation Immunology Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer Inc
11.1.1 Pfizer Inc Company Information
11.1.2 Pfizer Inc Next-Generation Immunology Drugs Product Offered
11.1.3 Pfizer Inc Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Pfizer Inc Main Business Overview
11.1.5 Pfizer Inc Latest Developments
11.2 Abbvie Inc.
11.2.1 Abbvie Inc. Company Information
11.2.2 Abbvie Inc. Next-Generation Immunology Drugs Product Offered
11.2.3 Abbvie Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Abbvie Inc. Main Business Overview
11.2.5 Abbvie Inc. Latest Developments
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Company Information
11.3.2 Johnson and Johnson Next-Generation Immunology Drugs Product Offered
11.3.3 Johnson and Johnson Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Johnson and Johnson Main Business Overview
11.3.5 Johnson and Johnson Latest Developments
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 F. Hoffmann-La Roche Ltd. Company Information
11.4.2 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Product Offered
11.4.3 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.4.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.5 Amgen Inc.
11.5.1 Amgen Inc. Company Information
11.5.2 Amgen Inc. Next-Generation Immunology Drugs Product Offered
11.5.3 Amgen Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Amgen Inc. Main Business Overview
11.5.5 Amgen Inc. Latest Developments
11.6 Novartis AG
11.6.1 Novartis AG Company Information
11.6.2 Novartis AG Next-Generation Immunology Drugs Product Offered
11.6.3 Novartis AG Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Novartis AG Main Business Overview
11.6.5 Novartis AG Latest Developments
11.7 Astellas Pharma Inc.
11.7.1 Astellas Pharma Inc. Company Information
11.7.2 Astellas Pharma Inc. Next-Generation Immunology Drugs Product Offered
11.7.3 Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Astellas Pharma Inc. Main Business Overview
11.7.5 Astellas Pharma Inc. Latest Developments
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Company Information
11.8.2 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Product Offered
11.8.3 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Bristol-Myers Squibb Company Main Business Overview
11.8.5 Bristol-Myers Squibb Company Latest Developments
11.9 Merck & Co., Inc.
11.9.1 Merck & Co., Inc. Company Information
11.9.2 Merck & Co., Inc. Next-Generation Immunology Drugs Product Offered
11.9.3 Merck & Co., Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Merck & Co., Inc. Main Business Overview
11.9.5 Merck & Co., Inc. Latest Developments
11.10 Eli Lilly and Company
11.10.1 Eli Lilly and Company Company Information
11.10.2 Eli Lilly and Company Next-Generation Immunology Drugs Product Offered
11.10.3 Eli Lilly and Company Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Eli Lilly and Company Main Business Overview
11.10.5 Eli Lilly and Company Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Next-Generation Immunology Drugs Market Size (2021-2032)
2.1.2 Next-Generation Immunology Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Next-Generation Immunology Drugs by Country/Region (2021, 2025 & 2032)
2.2 Next-Generation Immunology Drugs Segment by Type
2.2.1 Cell Therapy
2.2.2 Small Molecule Drug
2.2.3 Others
2.2.4 Next-Generation Immunology Drugs Market Size by Type
2.2.4.1 Next-Generation Immunology Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Next-Generation Immunology Drugs Market Size Market Share by Type (2021-2026)
2.3 Next-Generation Immunology Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Next-Generation Immunology Drugs Market Size by Application
2.3.4.1 Next-Generation Immunology Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Next-Generation Immunology Drugs Market Size Market Share by Application (2021-2026)
3 NEXT-GENERATION IMMUNOLOGY DRUGS MARKET SIZE BY PLAYER
3.1 Next-Generation Immunology Drugs Market Size Market Share by Player
3.1.1 Global Next-Generation Immunology Drugs Revenue by Player (2021-2026)
3.1.2 Global Next-Generation Immunology Drugs Revenue Market Share by Player (2021-2026)
3.2 Global Next-Generation Immunology Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEXT-GENERATION IMMUNOLOGY DRUGS BY REGION
4.1 Next-Generation Immunology Drugs Market Size by Region (2021-2026)
4.2 Global Next-Generation Immunology Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Next-Generation Immunology Drugs Market Size Growth (2021-2026)
4.4 APAC Next-Generation Immunology Drugs Market Size Growth (2021-2026)
4.5 Europe Next-Generation Immunology Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa Next-Generation Immunology Drugs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Next-Generation Immunology Drugs Market Size by Country (2021-2026)
5.2 Americas Next-Generation Immunology Drugs Market Size by Type (2021-2026)
5.3 Americas Next-Generation Immunology Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Next-Generation Immunology Drugs Market Size by Region (2021-2026)
6.2 APAC Next-Generation Immunology Drugs Market Size by Type (2021-2026)
6.3 APAC Next-Generation Immunology Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Next-Generation Immunology Drugs Market Size by Country (2021-2026)
7.2 Europe Next-Generation Immunology Drugs Market Size by Type (2021-2026)
7.3 Europe Next-Generation Immunology Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Next-Generation Immunology Drugs by Region (2021-2026)
8.2 Middle East & Africa Next-Generation Immunology Drugs Market Size by Type (2021-2026)
8.3 Middle East & Africa Next-Generation Immunology Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEXT-GENERATION IMMUNOLOGY DRUGS MARKET FORECAST
10.1 Global Next-Generation Immunology Drugs Forecast by Region (2027-2032)
10.1.1 Global Next-Generation Immunology Drugs Forecast by Region (2027-2032)
10.1.2 Americas Next-Generation Immunology Drugs Forecast
10.1.3 APAC Next-Generation Immunology Drugs Forecast
10.1.4 Europe Next-Generation Immunology Drugs Forecast
10.1.5 Middle East & Africa Next-Generation Immunology Drugs Forecast
10.2 Americas Next-Generation Immunology Drugs Forecast by Country (2027-2032)
10.2.1 United States Market Next-Generation Immunology Drugs Forecast
10.2.2 Canada Market Next-Generation Immunology Drugs Forecast
10.2.3 Mexico Market Next-Generation Immunology Drugs Forecast
10.2.4 Brazil Market Next-Generation Immunology Drugs Forecast
10.3 APAC Next-Generation Immunology Drugs Forecast by Region (2027-2032)
10.3.1 China Next-Generation Immunology Drugs Market Forecast
10.3.2 Japan Market Next-Generation Immunology Drugs Forecast
10.3.3 Korea Market Next-Generation Immunology Drugs Forecast
10.3.4 Southeast Asia Market Next-Generation Immunology Drugs Forecast
10.3.5 India Market Next-Generation Immunology Drugs Forecast
10.3.6 Australia Market Next-Generation Immunology Drugs Forecast
10.4 Europe Next-Generation Immunology Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market Next-Generation Immunology Drugs Forecast
10.4.2 France Market Next-Generation Immunology Drugs Forecast
10.4.3 UK Market Next-Generation Immunology Drugs Forecast
10.4.4 Italy Market Next-Generation Immunology Drugs Forecast
10.4.5 Russia Market Next-Generation Immunology Drugs Forecast
10.5 Middle East & Africa Next-Generation Immunology Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market Next-Generation Immunology Drugs Forecast
10.5.2 South Africa Market Next-Generation Immunology Drugs Forecast
10.5.3 Israel Market Next-Generation Immunology Drugs Forecast
10.5.4 Turkey Market Next-Generation Immunology Drugs Forecast
10.6 Global Next-Generation Immunology Drugs Forecast by Type (2027-2032)
10.7 Global Next-Generation Immunology Drugs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Next-Generation Immunology Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer Inc
11.1.1 Pfizer Inc Company Information
11.1.2 Pfizer Inc Next-Generation Immunology Drugs Product Offered
11.1.3 Pfizer Inc Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Pfizer Inc Main Business Overview
11.1.5 Pfizer Inc Latest Developments
11.2 Abbvie Inc.
11.2.1 Abbvie Inc. Company Information
11.2.2 Abbvie Inc. Next-Generation Immunology Drugs Product Offered
11.2.3 Abbvie Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Abbvie Inc. Main Business Overview
11.2.5 Abbvie Inc. Latest Developments
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Company Information
11.3.2 Johnson and Johnson Next-Generation Immunology Drugs Product Offered
11.3.3 Johnson and Johnson Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Johnson and Johnson Main Business Overview
11.3.5 Johnson and Johnson Latest Developments
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 F. Hoffmann-La Roche Ltd. Company Information
11.4.2 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Product Offered
11.4.3 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.4.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.5 Amgen Inc.
11.5.1 Amgen Inc. Company Information
11.5.2 Amgen Inc. Next-Generation Immunology Drugs Product Offered
11.5.3 Amgen Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Amgen Inc. Main Business Overview
11.5.5 Amgen Inc. Latest Developments
11.6 Novartis AG
11.6.1 Novartis AG Company Information
11.6.2 Novartis AG Next-Generation Immunology Drugs Product Offered
11.6.3 Novartis AG Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Novartis AG Main Business Overview
11.6.5 Novartis AG Latest Developments
11.7 Astellas Pharma Inc.
11.7.1 Astellas Pharma Inc. Company Information
11.7.2 Astellas Pharma Inc. Next-Generation Immunology Drugs Product Offered
11.7.3 Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Astellas Pharma Inc. Main Business Overview
11.7.5 Astellas Pharma Inc. Latest Developments
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Company Information
11.8.2 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Product Offered
11.8.3 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Bristol-Myers Squibb Company Main Business Overview
11.8.5 Bristol-Myers Squibb Company Latest Developments
11.9 Merck & Co., Inc.
11.9.1 Merck & Co., Inc. Company Information
11.9.2 Merck & Co., Inc. Next-Generation Immunology Drugs Product Offered
11.9.3 Merck & Co., Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Merck & Co., Inc. Main Business Overview
11.9.5 Merck & Co., Inc. Latest Developments
11.10 Eli Lilly and Company
11.10.1 Eli Lilly and Company Company Information
11.10.2 Eli Lilly and Company Next-Generation Immunology Drugs Product Offered
11.10.3 Eli Lilly and Company Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Eli Lilly and Company Main Business Overview
11.10.5 Eli Lilly and Company Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Next-Generation Immunology Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Next-Generation Immunology Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cell Therapy
Table 4. Major Players of Small Molecule Drug
Table 5. Major Players of Others
Table 6. Next-Generation Immunology Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Next-Generation Immunology Drugs Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Next-Generation Immunology Drugs Market Size Market Share by Type (2021-2026)
Table 9. Next-Generation Immunology Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Next-Generation Immunology Drugs Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Next-Generation Immunology Drugs Market Size Market Share by Application (2021-2026)
Table 12. Global Next-Generation Immunology Drugs Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Next-Generation Immunology Drugs Revenue Market Share by Player (2021-2026)
Table 14. Next-Generation Immunology Drugs Key Players Head office and Products Offered
Table 15. Next-Generation Immunology Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Next-Generation Immunology Drugs Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Next-Generation Immunology Drugs Market Size Market Share by Region (2021-2026)
Table 20. Global Next-Generation Immunology Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Next-Generation Immunology Drugs Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Next-Generation Immunology Drugs Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Next-Generation Immunology Drugs Market Size Market Share by Country (2021-2026)
Table 24. Americas Next-Generation Immunology Drugs Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Next-Generation Immunology Drugs Market Size Market Share by Type (2021-2026)
Table 26. Americas Next-Generation Immunology Drugs Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Next-Generation Immunology Drugs Market Size Market Share by Application (2021-2026)
Table 28. APAC Next-Generation Immunology Drugs Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Next-Generation Immunology Drugs Market Size Market Share by Region (2021-2026)
Table 30. APAC Next-Generation Immunology Drugs Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Next-Generation Immunology Drugs Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Next-Generation Immunology Drugs Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Next-Generation Immunology Drugs Market Size Market Share by Country (2021-2026)
Table 34. Europe Next-Generation Immunology Drugs Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Next-Generation Immunology Drugs Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Next-Generation Immunology Drugs Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Next-Generation Immunology Drugs Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Next-Generation Immunology Drugs Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Next-Generation Immunology Drugs
Table 40. Key Market Challenges & Risks of Next-Generation Immunology Drugs
Table 41. Key Industry Trends of Next-Generation Immunology Drugs
Table 42. Global Next-Generation Immunology Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Next-Generation Immunology Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Next-Generation Immunology Drugs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Next-Generation Immunology Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Pfizer Inc Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 47. Pfizer Inc Next-Generation Immunology Drugs Product Offered
Table 48. Pfizer Inc Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Pfizer Inc Main Business
Table 50. Pfizer Inc Latest Developments
Table 51. Abbvie Inc. Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 52. Abbvie Inc. Next-Generation Immunology Drugs Product Offered
Table 53. Abbvie Inc. Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Abbvie Inc. Main Business
Table 55. Abbvie Inc. Latest Developments
Table 56. Johnson and Johnson Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 57. Johnson and Johnson Next-Generation Immunology Drugs Product Offered
Table 58. Johnson and Johnson Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Johnson and Johnson Main Business
Table 60. Johnson and Johnson Latest Developments
Table 61. F. Hoffmann-La Roche Ltd. Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 62. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Product Offered
Table 63. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. F. Hoffmann-La Roche Ltd. Main Business
Table 65. F. Hoffmann-La Roche Ltd. Latest Developments
Table 66. Amgen Inc. Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 67. Amgen Inc. Next-Generation Immunology Drugs Product Offered
Table 68. Amgen Inc. Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Amgen Inc. Main Business
Table 70. Amgen Inc. Latest Developments
Table 71. Novartis AG Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 72. Novartis AG Next-Generation Immunology Drugs Product Offered
Table 73. Novartis AG Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Novartis AG Main Business
Table 75. Novartis AG Latest Developments
Table 76. Astellas Pharma Inc. Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 77. Astellas Pharma Inc. Next-Generation Immunology Drugs Product Offered
Table 78. Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Astellas Pharma Inc. Main Business
Table 80. Astellas Pharma Inc. Latest Developments
Table 81. Bristol-Myers Squibb Company Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 82. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Product Offered
Table 83. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Bristol-Myers Squibb Company Main Business
Table 85. Bristol-Myers Squibb Company Latest Developments
Table 86. Merck & Co., Inc. Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 87. Merck & Co., Inc. Next-Generation Immunology Drugs Product Offered
Table 88. Merck & Co., Inc. Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Merck & Co., Inc. Main Business
Table 90. Merck & Co., Inc. Latest Developments
Table 91. Eli Lilly and Company Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 92. Eli Lilly and Company Next-Generation Immunology Drugs Product Offered
Table 93. Eli Lilly and Company Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Eli Lilly and Company Main Business
Table 95. Eli Lilly and Company Latest Developments
Table 1. Next-Generation Immunology Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Next-Generation Immunology Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cell Therapy
Table 4. Major Players of Small Molecule Drug
Table 5. Major Players of Others
Table 6. Next-Generation Immunology Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Next-Generation Immunology Drugs Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Next-Generation Immunology Drugs Market Size Market Share by Type (2021-2026)
Table 9. Next-Generation Immunology Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Next-Generation Immunology Drugs Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Next-Generation Immunology Drugs Market Size Market Share by Application (2021-2026)
Table 12. Global Next-Generation Immunology Drugs Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Next-Generation Immunology Drugs Revenue Market Share by Player (2021-2026)
Table 14. Next-Generation Immunology Drugs Key Players Head office and Products Offered
Table 15. Next-Generation Immunology Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Next-Generation Immunology Drugs Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Next-Generation Immunology Drugs Market Size Market Share by Region (2021-2026)
Table 20. Global Next-Generation Immunology Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Next-Generation Immunology Drugs Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Next-Generation Immunology Drugs Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Next-Generation Immunology Drugs Market Size Market Share by Country (2021-2026)
Table 24. Americas Next-Generation Immunology Drugs Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Next-Generation Immunology Drugs Market Size Market Share by Type (2021-2026)
Table 26. Americas Next-Generation Immunology Drugs Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Next-Generation Immunology Drugs Market Size Market Share by Application (2021-2026)
Table 28. APAC Next-Generation Immunology Drugs Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Next-Generation Immunology Drugs Market Size Market Share by Region (2021-2026)
Table 30. APAC Next-Generation Immunology Drugs Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Next-Generation Immunology Drugs Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Next-Generation Immunology Drugs Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Next-Generation Immunology Drugs Market Size Market Share by Country (2021-2026)
Table 34. Europe Next-Generation Immunology Drugs Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Next-Generation Immunology Drugs Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Next-Generation Immunology Drugs Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Next-Generation Immunology Drugs Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Next-Generation Immunology Drugs Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Next-Generation Immunology Drugs
Table 40. Key Market Challenges & Risks of Next-Generation Immunology Drugs
Table 41. Key Industry Trends of Next-Generation Immunology Drugs
Table 42. Global Next-Generation Immunology Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Next-Generation Immunology Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Next-Generation Immunology Drugs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Next-Generation Immunology Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Pfizer Inc Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 47. Pfizer Inc Next-Generation Immunology Drugs Product Offered
Table 48. Pfizer Inc Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Pfizer Inc Main Business
Table 50. Pfizer Inc Latest Developments
Table 51. Abbvie Inc. Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 52. Abbvie Inc. Next-Generation Immunology Drugs Product Offered
Table 53. Abbvie Inc. Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Abbvie Inc. Main Business
Table 55. Abbvie Inc. Latest Developments
Table 56. Johnson and Johnson Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 57. Johnson and Johnson Next-Generation Immunology Drugs Product Offered
Table 58. Johnson and Johnson Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Johnson and Johnson Main Business
Table 60. Johnson and Johnson Latest Developments
Table 61. F. Hoffmann-La Roche Ltd. Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 62. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Product Offered
Table 63. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. F. Hoffmann-La Roche Ltd. Main Business
Table 65. F. Hoffmann-La Roche Ltd. Latest Developments
Table 66. Amgen Inc. Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 67. Amgen Inc. Next-Generation Immunology Drugs Product Offered
Table 68. Amgen Inc. Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Amgen Inc. Main Business
Table 70. Amgen Inc. Latest Developments
Table 71. Novartis AG Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 72. Novartis AG Next-Generation Immunology Drugs Product Offered
Table 73. Novartis AG Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Novartis AG Main Business
Table 75. Novartis AG Latest Developments
Table 76. Astellas Pharma Inc. Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 77. Astellas Pharma Inc. Next-Generation Immunology Drugs Product Offered
Table 78. Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Astellas Pharma Inc. Main Business
Table 80. Astellas Pharma Inc. Latest Developments
Table 81. Bristol-Myers Squibb Company Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 82. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Product Offered
Table 83. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Bristol-Myers Squibb Company Main Business
Table 85. Bristol-Myers Squibb Company Latest Developments
Table 86. Merck & Co., Inc. Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 87. Merck & Co., Inc. Next-Generation Immunology Drugs Product Offered
Table 88. Merck & Co., Inc. Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Merck & Co., Inc. Main Business
Table 90. Merck & Co., Inc. Latest Developments
Table 91. Eli Lilly and Company Details, Company Type, Next-Generation Immunology Drugs Area Served and Its Competitors
Table 92. Eli Lilly and Company Next-Generation Immunology Drugs Product Offered
Table 93. Eli Lilly and Company Next-Generation Immunology Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Eli Lilly and Company Main Business
Table 95. Eli Lilly and Company Latest Developments
LIST OF FIGURES
Figure 1. Next-Generation Immunology Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Next-Generation Immunology Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Next-Generation Immunology Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Next-Generation Immunology Drugs Sales Market Share by Country/Region (2025)
Figure 8. Next-Generation Immunology Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Next-Generation Immunology Drugs Market Size Market Share by Type in 2025
Figure 10. Next-Generation Immunology Drugs in Hospital
Figure 11. Global Next-Generation Immunology Drugs Market: Hospital (2021-2026) & ($ millions)
Figure 12. Next-Generation Immunology Drugs in Clinic
Figure 13. Global Next-Generation Immunology Drugs Market: Clinic (2021-2026) & ($ millions)
Figure 14. Next-Generation Immunology Drugs in Others
Figure 15. Global Next-Generation Immunology Drugs Market: Others (2021-2026) & ($ millions)
Figure 16. Global Next-Generation Immunology Drugs Market Size Market Share by Application in 2025
Figure 17. Global Next-Generation Immunology Drugs Revenue Market Share by Player in 2025
Figure 18. Global Next-Generation Immunology Drugs Market Size Market Share by Region (2021-2026)
Figure 19. Americas Next-Generation Immunology Drugs Market Size 2021-2026 ($ millions)
Figure 20. APAC Next-Generation Immunology Drugs Market Size 2021-2026 ($ millions)
Figure 21. Europe Next-Generation Immunology Drugs Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Next-Generation Immunology Drugs Market Size 2021-2026 ($ millions)
Figure 23. Americas Next-Generation Immunology Drugs Value Market Share by Country in 2025
Figure 24. United States Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Next-Generation Immunology Drugs Market Size Market Share by Region in 2025
Figure 29. APAC Next-Generation Immunology Drugs Market Size Market Share by Type (2021-2026)
Figure 30. APAC Next-Generation Immunology Drugs Market Size Market Share by Application (2021-2026)
Figure 31. China Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. India Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Next-Generation Immunology Drugs Market Size Market Share by Country in 2025
Figure 38. Europe Next-Generation Immunology Drugs Market Size Market Share by Type (2021-2026)
Figure 39. Europe Next-Generation Immunology Drugs Market Size Market Share by Application (2021-2026)
Figure 40. Germany Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 41. France Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Next-Generation Immunology Drugs Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Next-Generation Immunology Drugs Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Next-Generation Immunology Drugs Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 54. APAC Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 55. Europe Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 57. United States Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 58. Canada Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 59. Mexico Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 60. Brazil Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 61. China Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 62. Japan Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 63. Korea Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 65. India Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 66. Australia Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 67. Germany Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 68. France Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 69. UK Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 70. Italy Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 71. Russia Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 72. Egypt Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 73. South Africa Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 74. Israel Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 75. Turkey Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 76. Global Next-Generation Immunology Drugs Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Next-Generation Immunology Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 1. Next-Generation Immunology Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Next-Generation Immunology Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Next-Generation Immunology Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Next-Generation Immunology Drugs Sales Market Share by Country/Region (2025)
Figure 8. Next-Generation Immunology Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Next-Generation Immunology Drugs Market Size Market Share by Type in 2025
Figure 10. Next-Generation Immunology Drugs in Hospital
Figure 11. Global Next-Generation Immunology Drugs Market: Hospital (2021-2026) & ($ millions)
Figure 12. Next-Generation Immunology Drugs in Clinic
Figure 13. Global Next-Generation Immunology Drugs Market: Clinic (2021-2026) & ($ millions)
Figure 14. Next-Generation Immunology Drugs in Others
Figure 15. Global Next-Generation Immunology Drugs Market: Others (2021-2026) & ($ millions)
Figure 16. Global Next-Generation Immunology Drugs Market Size Market Share by Application in 2025
Figure 17. Global Next-Generation Immunology Drugs Revenue Market Share by Player in 2025
Figure 18. Global Next-Generation Immunology Drugs Market Size Market Share by Region (2021-2026)
Figure 19. Americas Next-Generation Immunology Drugs Market Size 2021-2026 ($ millions)
Figure 20. APAC Next-Generation Immunology Drugs Market Size 2021-2026 ($ millions)
Figure 21. Europe Next-Generation Immunology Drugs Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Next-Generation Immunology Drugs Market Size 2021-2026 ($ millions)
Figure 23. Americas Next-Generation Immunology Drugs Value Market Share by Country in 2025
Figure 24. United States Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Next-Generation Immunology Drugs Market Size Market Share by Region in 2025
Figure 29. APAC Next-Generation Immunology Drugs Market Size Market Share by Type (2021-2026)
Figure 30. APAC Next-Generation Immunology Drugs Market Size Market Share by Application (2021-2026)
Figure 31. China Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. India Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Next-Generation Immunology Drugs Market Size Market Share by Country in 2025
Figure 38. Europe Next-Generation Immunology Drugs Market Size Market Share by Type (2021-2026)
Figure 39. Europe Next-Generation Immunology Drugs Market Size Market Share by Application (2021-2026)
Figure 40. Germany Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 41. France Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Next-Generation Immunology Drugs Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Next-Generation Immunology Drugs Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Next-Generation Immunology Drugs Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Next-Generation Immunology Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 54. APAC Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 55. Europe Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 57. United States Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 58. Canada Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 59. Mexico Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 60. Brazil Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 61. China Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 62. Japan Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 63. Korea Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 65. India Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 66. Australia Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 67. Germany Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 68. France Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 69. UK Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 70. Italy Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 71. Russia Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 72. Egypt Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 73. South Africa Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 74. Israel Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 75. Turkey Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
Figure 76. Global Next-Generation Immunology Drugs Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Next-Generation Immunology Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Next-Generation Immunology Drugs Market Size 2027-2032 ($ millions)
